Introduction
Neuromodulators (often called by brand names such as Botox) and hyaluronic acid fillers are common office procedures. Demand has grown as techniques improve—but safety depends on anatomy, product, and operator. For regulatory context in the United States, the FDA botulinum toxin consumer update describes risks such as distant spread of toxin effect when products are mishandled; in Canada, only Health Canada-authorized devices and drugs should be used for approved indications. The AAD cosmetic overview offers patient-friendly explanations.
Neuromodulators (e.g., botulinum toxin type A)
Mechanism
Temporarily reduces muscle contraction in treated areas, softening dynamic lines (formed with expression). It does not remove static sun damage or replace lost volume.
Typical areas & timelines
Upper face lines are common off-label/on-label targets depending on product monograph—your injector should cite the specific indication. Onset often 3–7 days; peak near two weeks; duration commonly ~3–4 months, variable by dose and muscle strength.
Safety
Avoid elective cosmetic toxin in pregnancy/breastfeeding. Neuromuscular disease and aminoglycoside antibiotics may interact—disclose all meds. Eyelid droop, asymmetry, and headache can occur; choose injectors trained in facial anatomy and complication management.
Hyaluronic acid fillers
Mechanism
Gel implants restore volume or smooth folds. Results are immediate but evolve as swelling resolves (~2 weeks for many areas).
Vascular risk
Intravascular injection is a rare but vision-threatening emergency—reason to choose experienced medical injectors with hyaluronidase available for hyaluronic acid reversal when appropriate.
Duration
Often 6–18+ months depending on product cohesivity, depth, and area (lips metabolize faster than some deep cheek placements).
Aftercare
Avoid vigorous massage unless instructed; follow ice and activity restrictions from your clinician. Bruising risk rises with NSAIDs, alcohol, and some supplements—discuss holds before elective treatment.
Conclusion
Injectables can be effective when goals, anatomy, and risks align. At Trita Medical Clinic, treatments are medically supervised with emphasis on natural progression—not trends. Book a consultation for individualized planning.
Written by Maryam Ajami, MD
Head of Cosmetic Medicine
Maryam Ajami, MD, leads cosmetic medicine at Trita. With over ten years of clinical experience, training in otolaryngology (head and neck), and leadership roles in medical aesthetics in Ottawa—including Medical Aesthetic Team Lead at Victoria Park Medispa and Medical Aesthetician Manager at Kanata Skin Clinic—she focuses on safe, medically supervised aesthetic treatments and natural-looking results.
